Home

Scott Applebaum

CIK 1618945 · CLCO; SVP, Regulatory Affairs · last filed 2023-06-20

Scott Applebaum is a CLCO; SVP, Regulatory Affairs who has filed 10 SEC Form 4 insider transactions across 5 companies since 2014. The most recent filing, for CINGW, was dated Jun 20, 2023. Across all open-market trades the lifetime net is +$25.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $3.8K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.8K

Companies

5

Total Filings

10

Lifetime Open-Market Net

$25.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CINGW Director — $0.03 — $0 2 2023-06-20
TRVN CLCO; SVP, Regulatory Affairs 344,022 $0.01 $3.8K $0 3 2021-02-12
Vitae Pharmaceuticals, Inc (VTAE) Delisted General Counsel — — — $0 2 2016-10-25
Aevi Genomic Medicine, LLC (MDGN) Delisted Chief Legal Officer — — — $0 1 2016-04-19
Aevi Genomic Medicine, LLC (MDGN.WS) Delisted Chief Legal Officer 6,098 — — $25.0K 2 2014-12-02

Recent Filings

10 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-06-20 CINGW Grant (A) — $0 EDGAR
2022-08-11 CINGW Grant (A) — $0 EDGAR
2021-02-12 TRVN Tax (F) −21,178 -$60.4K EDGAR
2020-12-18 TRVN Grant (A) +115,200 $0 EDGAR
2020-02-12 TRVN Grant (A) +250,000 $0 EDGAR
2016-10-25 Vitae Pharmaceuticals, Inc (VTAE) Delisted Disp (D) — $0 EDGAR
2016-08-12 Vitae Pharmaceuticals, Inc (VTAE) Delisted Grant (A) — $0 EDGAR
2016-04-19 Aevi Genomic Medicine, LLC (MDGN) Delisted Grant (A) — $0 EDGAR
2014-12-02 Aevi Genomic Medicine, LLC (MDGN.WS) Delisted Buy (P) +6,098 $25.0K EDGAR
2014-09-10 Aevi Genomic Medicine, LLC (MDGN.WS) Delisted Grant (A) — $0 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.